Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further-Reference-Cited by-同舟云学术

Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further

Published:2016 Issue:2 Volume:38 Page:129-138
ISSN:0387-821X
Container-title:Journal of UOEH
language:en
Short-container-title:J UOEH

Author:

FUJIMOTO Naohiro¹

Affiliation:

1. Department of Urology, School of Medicine, University of Occupational and Environmental Health, Japan

Publisher

The University of Occupational and Environmental Health, Japan

Subject

Public Health, Environmental and Occupational Health,General Medicine

Link

https://www.jstage.jst.go.jp/article/juoeh/38/2/38_129/_pdf

Reference63 articles.

1. 1. National Cancer Center (2015): Projected cancer incidence in 2015, Projected Cancer Statistics, 2015, Tokyo http://ganjoho.jp/en/public/statistics/short_pred.html, [Feb 15 2016]

2. 2. Huggins C & Hodges CV (1941): Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293-297

3. 3. Chung PH, Gayed BA, Thoreson GR & Raj GV (2013): Emerging drugs for prostate cancer. Expert Opin Emerg Drugs 18: 533-550

4. 4. Labrie F (2011): Blockade of testicular and adrenal androgens in prostate cancer treatment. Nat Rev Urol 8: 73-85

5. 5. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD & Nelson PS (2008): Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res 68: 4447-4454

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manganese as a Possible Anticancer Enhancer in Docetaxel Treatment of Prostate Cancer Cells;Anticancer Research;2024-02-29

2. Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment;Journal of Medicinal Chemistry;2023-05-16

3. Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression;The Journal of Pathology: Clinical Research;2023-04-18

4. RECENT ADVANCES IN TARGETING THE ANDROGEN RECEPTOR WITH PROTACS;2022 Medicinal Chemistry Reviews;2022-12-21

5. Therapeutic Strategies to Target the Androgen Receptor;Journal of Medicinal Chemistry;2022-07-05